| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.12 | 6e-05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.4 | 0.0002 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0003 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.18 | 0.0004 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |